Advertisement

Astonea Labs IPO opens right now: Right here’s what you’ll want to know earlier than subscribing


Thank you for reading this post, don't forget to subscribe!
The preliminary public providing (IPO) of Astonea Labs, an organization engaged in manufacturing pharmaceutical and beauty merchandise, will open for subscription on Might 27, and shut on Might 29. The corporate is aiming to lift Rs 37.67 crore by way of a recent problem of 27.90 lakh shares. It will likely be listed on the BSE SME platform, with a tentative itemizing date of June 3.

Oneview Company Advisors is the book-running lead supervisor, and KFin Applied sciences is the registrar to the problem.

Astonea Labs IPO worth band

The worth band for the IPO is ready at Rs 128 to Rs 135 per share. Retail buyers can apply for no less than 1,000 shares, which requires an funding of Rs 1,35,000 on the higher worth band. Excessive-net-worth people (HNIs) can bid for no less than two heaps (2,000 shares), requiring Rs 2,70,000.

In regards to the firm

Based in 2017, Astonea Labs is concerned in contract manufacturing of a variety of pharmaceutical and beauty merchandise. Its choices embrace antibiotics, anti-cold medication, diabetic care, coronary heart and gynecological medicines, in addition to private care merchandise like gels, serums, lotions, and extra.


The corporate additionally markets its personal manufacturers — “Glow Up” (skincare) and “Regero” (pharma). It plans to launch one other model referred to as “Avicel” and exports its merchandise to nations like Iraq and Yemen.

Use of IPO Funds

The corporate will use the IPO proceeds for registration bills in Bolivia, buy of machines for ointment manufacturing, promoting and model promotion, shopping for IT {hardware} and software program, working capital wants and common company functions

Monetary snapshot

Astonea Labs posted a revenue of Rs 4.10 crore within the 9 months ended December 2024 on a income of Rs 69.69 crore. The corporate has proven sturdy development over time with a return on fairness (ROE) of 37.86% and PAT margin of 4.75%.

(Disclaimer: Suggestions, ideas, views and opinions given by the consultants are their very own. These don’t characterize the views of Financial Occasions)